IRIS
MALCOVATI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.318
AS - Asia 4.848
EU - Europa 3.542
SA - Sud America 832
AF - Africa 101
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 14
Totale 15.670
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.183
CN - Cina 2.463
SG - Singapore 1.093
IE - Irlanda 864
HK - Hong Kong 752
BR - Brasile 692
RU - Federazione Russa 429
UA - Ucraina 429
FI - Finlandia 427
DE - Germania 393
IT - Italia 341
VN - Vietnam 218
GB - Regno Unito 192
SE - Svezia 192
CA - Canada 67
FR - Francia 57
AR - Argentina 52
IN - India 49
MX - Messico 46
JP - Giappone 45
AT - Austria 42
NL - Olanda 36
BD - Bangladesh 35
PL - Polonia 31
ZA - Sudafrica 31
IQ - Iraq 28
TR - Turchia 27
ES - Italia 25
BE - Belgio 24
EC - Ecuador 22
ID - Indonesia 16
PY - Paraguay 14
IL - Israele 13
VE - Venezuela 13
CO - Colombia 12
KE - Kenya 12
AU - Australia 11
PK - Pakistan 11
EU - Europa 10
PE - Perù 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
LT - Lituania 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
CL - Cile 8
KR - Corea 8
TN - Tunisia 8
EG - Egitto 7
CH - Svizzera 6
MU - Mauritius 6
NG - Nigeria 6
CR - Costa Rica 5
IR - Iran 5
JO - Giordania 5
MA - Marocco 5
NP - Nepal 5
OM - Oman 5
PH - Filippine 5
BO - Bolivia 4
DK - Danimarca 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LV - Lettonia 4
PS - Palestinian Territory 4
AO - Angola 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GR - Grecia 3
HN - Honduras 3
HU - Ungheria 3
LB - Libano 3
NZ - Nuova Zelanda 3
PA - Panama 3
RO - Romania 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
BG - Bulgaria 2
BW - Botswana 2
BY - Bielorussia 2
CY - Cipro 2
ET - Etiopia 2
GH - Ghana 2
GT - Guatemala 2
JM - Giamaica 2
KW - Kuwait 2
MN - Mongolia 2
MR - Mauritania 2
MT - Malta 2
NI - Nicaragua 2
NO - Norvegia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
Totale 15.645
Salva come PNG Salva come JPEG
Città #
Chandler 911
Dublin 863
Hong Kong 752
Dallas 584
Jacksonville 583
Ashburn 538
Nanjing 524
Singapore 457
Boardman 375
Beijing 363
Princeton 210
Nanchang 197
Lawrence 196
Medford 187
Wilmington 170
Los Angeles 159
New York 156
Changsha 153
Hebei 145
Shenyang 138
Jiaxing 119
Buffalo 115
Helsinki 115
Redondo Beach 90
Tianjin 88
Ann Arbor 84
Milan 82
Hangzhou 80
Ho Chi Minh City 80
Moscow 76
Shanghai 73
Munich 71
Pavia 66
São Paulo 57
The Dalles 57
Seattle 54
Hanoi 49
Nuremberg 46
Tokyo 38
Woodbridge 38
Norwalk 35
Turku 35
Toronto 32
Chicago 31
Warsaw 30
Washington 30
Belo Horizonte 28
San Francisco 28
Brooklyn 27
Brussels 24
Fairfield 22
Santa Clara 22
Verona 21
Denver 20
Guangzhou 20
Jinan 20
London 20
Orem 20
San Jose 20
Montreal 19
Columbus 18
Zhengzhou 18
Boston 17
Falls Church 16
Poplar 16
Brasília 15
Haiphong 15
Rio de Janeiro 15
Stockholm 15
Atlanta 14
Des Moines 14
Johannesburg 14
Kunming 14
Mexico City 14
Vienna 14
Amsterdam 13
Ankara 13
Chennai 13
Frankfurt am Main 13
Falkenstein 12
Nairobi 12
Dearborn 11
Redwood City 11
Houston 10
Ningbo 10
Rome 10
Juiz de Fora 9
Phoenix 9
Ribeirão Preto 9
Baku 8
Campinas 8
Charlotte 8
Curitiba 8
Fuzhou 8
Porto Alegre 8
Shenzhen 8
Taizhou 8
Tashkent 8
Wuhan 8
Asunción 7
Totale 10.114
Salva come PNG Salva come JPEG
Nome #
A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndrome. 149
Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. 132
A continuous-time Markov model approach for modeling myelodysplastic syndromes progression from cross-sectional data 131
A prognostic model for predicting the impact of comorbidities on survival of patients with myelodysplastic syndromes 129
ANALYSIS OF THE MITOCHONDRIAL FERRITIN PHYSIOPATHOLOGICAL ROLE IN SIDEROBLASTIC ERYTHROPOIESIS 123
A rule-based expert system for automatic implementation of somatic variant clinical interpretation guidelines 123
A novel t(Y;11) translocation with MLL gene rearrangement in a case of acute myelomonocytic leukemia (AML-M4) 122
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes 122
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndrome 118
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts 118
Assessment of chimerism in sex-mismatched allogeneic bone marrrow transplants (allo-BMT) by in situ hybridization and cytogenetics. Is host cell percentage predictive of relapse? 116
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2 P95-mutated neoplasms 116
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia 113
Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders 112
Classification and prognostic evaluation of myelodysplastic syndromes 110
Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes. 109
Circulating endothelial cell separation from peripheral blood of patients affected by myelodysplastic syndromes: Preliminary results obtained by a new immunomagnetic procedure 109
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel. 108
Aplastic anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2010. 103
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 102
Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome 101
Clinical significance of somatic mutation in unexplained blood cytopenia 100
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). 99
Complex Patterns of Chromosome 11 Aberrations in Myeloid Malignancies Target CBL, MLL, DDB1 and LMO2. 99
Myelodysplastic syndromes: diagnosis and staging. 98
Clinical and biological implications of driver mutations in myelodysplastic syndromes 98
Revised international prognostic scoring system for myelodysplastic syndromes 97
CHARACTERIZATION OF A CELLULAR MODEL FOR THE STUDY OF MITOCHONDRIAL FERRITIN PHYSIOPATHOLOGICAL ROLE IN SIDEROBLASTIC ERYTHROPOIESIS 95
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System. 92
Myelodysplastic syndromes--coping with ineffective hematopoiesis. 91
The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications 91
Effects of mitochondrial ferritin overexpression in normal and sideroblastic erythroid progenitors. 89
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo. 89
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms 89
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance. 89
Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome. 88
Appreci8: A pipeline for precise variant calling integrating 8 tools 88
Disclosing the impact of carcinogenic SF3b mutations on pre-mRNA recognition via all-atom simulations 88
Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia 87
Hematologic passport for athletes competing in endurance sports: a feasibility study. 87
Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study. 87
Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms. 87
Clinical evaluation of extra-hematological comorbidity in myelodysplastic syndromes: "ready-to-wear" versus "made-to-measure" tools. 87
Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia. 87
A geno-clinical decision model for the diagnosis of myelodysplastic syndromes 86
Gene expression profiling of CD34+ cells in patients with the 5q- syndrome 86
Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes 86
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms 86
VASCULAR ENDOTHELIAL GROWTH FACTOR OVEREXPRESSION IN BONE MARROW CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME: BIOLOGICAL AND CLINICAL RELEVANCE 85
Peripheral arterial vascular function at altitude: sea-level natives versus Himalayan high-altitude natives 84
PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia 84
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia. 84
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults. 84
Relationship between clone metrics and clinical outcome in clonal cytopenia 83
Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. 83
Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms 82
ZBTB33 is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicing 81
Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome 81
From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging. 81
Clinical significance of genetic aberrations in secondary acute myeloid leukemia. 81
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 81
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 80
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies. 79
Morphological features and prognostic implication in a retrospective analysis of 370 patients with myelodysplastic syndrome 79
Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. 79
Haematological modifications after acute exposure to high altitude: possible implications for detection of recombinant erythropoietin misuse 78
Myelodysplastic/myeloproliferative disorders 78
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms 77
Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal- and translation-related genes 77
Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes 77
Haematological modifications after acute exposure to high altitude: possible implications for detection of recombinant erythropoietin misuse 77
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. 77
Fournier's gangrene: a clinical presentation of necrotizing fasciitis after bone marrow transplantation. 76
Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1 76
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts 76
Atomic-Level Mechanism of Pre-mRNA Splicing in Health and Disease 76
Reduced hypoxic ventilatory response with preserved blood oxygenation in yoga trainees and Himalayan Buddhist monks at altitude: evidence of a different adaptive strategy? 75
Simian virus 40 and lymphoproliferative disorder. 75
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. 75
Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implications 75
Pan-cancer analysis of whole genomes 75
Incidence and Prognosis of Clonal Hematopoiesis in patients with Chronic Idiopathic Neutropenia 75
Cerebral vasoreactivity in Andeans and headache at sea level. 74
Myelodysplastic/myeloproliferative neoplasms 74
Predicting survival and leukemic evolution in patients with myelodysplastic syndrome 74
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance. 74
Splenectomy for treatment of immune thrombocytopenic purpura. 73
Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes. 73
Genetic and clinical heterogeneity of ferroportin disease. 73
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications 72
Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes. 72
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. 72
Novel homeobox gene recombination in T-cell acute lymphoblastic leukemia. 72
Haematological modifications after acute exposure to high altitude: possible implications for detenction of recombinant erythropoietin misure 72
Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. 71
Risk factors for Gram-negative infections in neutropenic patients. 71
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet 71
Myelodysplastic syndromes with bone marrow fibrosis. 70
The genetic basis of myelodysplasia and its clinical relevance 70
Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes. 70
Totale 8.896
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.076
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.076
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021495 0 0 0 0 0 0 46 152 28 140 95 34
2021/2022917 15 4 15 15 34 34 12 42 57 34 143 512
2022/20232.553 272 138 20 234 248 264 2 165 1.050 25 96 39
2023/20241.160 85 199 58 78 113 327 29 69 10 23 78 91
2024/20253.174 75 286 106 84 72 195 203 228 653 170 366 736
2025/20264.256 544 693 909 919 866 320 5 0 0 0 0 0
Totale 16.140